Olympus launches new Powerseal Sealer/Divider 5mm devices extending advanced bipolar surgical energy portfolio
Olympus has launched two new jaw designs in the Powerseal Sealer/Divider range of advanced bipolar surgical energy products: the...
top of page
Browse by category
Search
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity
Eli Lilly and Company has announced Zepbound (tirzepatide) 2.5mg and 5mg single-dose vials are available for self-pay for patients with...
FDA expands Ethicon’s Linx Reflux Management System to include patients with Barrett’s esophagus experiencing GERD
The FDA has approved a label update to expand the availability of Ethicon’s Linx Reflux Management System to include patients with...
ANSM suspends Allurion gastric balloons in France
The Agence nationale de sécurité du médicament et des produits de santé (ANSM, National Medicines Safety Agency) in France has suspended...
FDA grants Breakthrough Device Designation for Fractyl’s Revita in weight maintenance for people with obesity who discontinue GLP-1s
The FDA has granted Breakthrough Device Designation (BDD) for Fractyl Health’s Revita System for use in the maintenance of weight loss...
Phenomix launches personalised obesity care genetic testing available to women in with Hello Alpha partnership
Phenomix Sciences has entered a partnership with Hello Alpha, a virtual primary care platform, to enable women to take control of their...
ReShape Lifesciences sells obesity devices to Biorad Medisys
ReShape has entered into an asset purchase agreement with Biorad Medisys, which is party to a previously disclosed exclusive license...
Introducing XNY Medical’s next-generation ENDO NOVA Powered Stapler
Bariatric News talked to Dr Jassim Fakhro, Senior Consultant in General, Metabolic, Bariatric and Robotic Surgery, Vice President of the...
iHerb launches new GLP-1 support products designed to combat common side effects from rapid weight loss
iHerb has launched three new supplements specifically designed to support individuals using semaglutide (GLP-1 agonists) by addressing...
WHO issues warning on falsified medicines as Lilly warns patients about counterfeit and compounded medicines
The World Health Organization (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for...
Browse by tag
bottom of page